Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24
CAS: 53784-84-2
Ref. TR-O237127
10mg | 517.00 € | ||
25mg | 1,210.00 € | ||
50mg | 1,848.00 € |
Product Information
- 2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-Hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontane-gamma-cyclodextrin-d24 Derivative
- 6A,6B,6C,6D,6E,6F,6G,6H-Octabromo-6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-gamma-cyclodextrin
- 6-Bromo-6-deoxy-gamma-cyclodextrin-d24
- 6-Bromo-6-deoxy-gamma-cyclodextrin-d24
- γ-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G,6H-octabromo-6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-
- 6A,6B,6C,6D,6E,6F,6G,6H-Octabromo-6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-γ-cyclodextrin
- Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin
- 6-Bromo-6-deoxy-γ-cyclodextrin
- 2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-Hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontane, γ-cyclodextrin deriv.
Applications Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24 is an intermediate in synthesizing Sugammadex Sodium-deuterated (S698102), which is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
References Welliver, M., et al.: Drug Des. Devel. Ther., 2, 49 (2008)
Chemical properties
Technical inquiry about: TR-O237127 Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.